Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2020
Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)Mario Mandalà, Francesca Galli, Roberto Patuzzo, et al.Cancer Immunology, Immunotherapy : CII|October 11, 2005
A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patientsLorenzo Pilla, Roberto Patuzzo, Licia Rivoltini, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I-modified peptidesPaola Filipazzi, Lorenzo Pilla, Luigi Mariani, et al.The Journal of Clinical Investigation|September 28, 2018
Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanomaVeronica Huber, Viviana Vallacchi, Viktor Fleming, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|March 16, 2023
Similar local recurrence and survival in patients with T1 radial growth phase melanoma on head and neck treated with 5 or 10 mm margins: A retrospective studyAndrea Maurichi, Francesco Barretta, Roberto Patuzzo, et al.Journal of Experimental & Clinical Cancer Research : CR|July 18, 2025
Integrated multi-omics profiling reveals the role of the DNA methylation landscape in shaping biological heterogeneity and clinical behaviour of metastatic melanomaAndrea Anichini, Francesca P Caruso, Vincenzo Lagano, et al.International Journal of Cancer|November 16, 2012
Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytesVincenzo Russo, Lorenzo Pilla, Francesca Lunghi, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
Analysis of Sentinel Node Biopsy and Clinicopathologic Features as Prognostic Factors in Patients With Atypical Melanocytic TumorsAndrea Maurichi, Rosalba Miceli, Roberto Patuzzo, et al.The British Journal of Surgery|May 3, 2023
European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanomaLuca G Campana, Sofia Farronato, Jackie Hodgetts, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2020
Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive NomogramAndrea Maurichi, Rosalba Miceli, Hanna Eriksson, et al.Pageof 5